BioPharma Credit (LON:BPCP) Shares Down 0.7% – Should You Sell?

BioPharma Credit PLC (LON:BPCPGet Free Report)’s stock price fell 0.7% during mid-day trading on Wednesday . The stock traded as low as GBX 71.66 and last traded at GBX 71.81. Approximately 332,780 shares traded hands during mid-day trading, an increase of 97% from the average session volume of 168,962 shares. The stock had previously closed at GBX 72.30.

BioPharma Credit Stock Performance

The stock has a market cap of £986.63 million, a PE ratio of 10.61 and a beta of 0.18. The stock has a fifty day moving average price of GBX 71.92 and a 200 day moving average price of GBX 70.41.

About BioPharma Credit

(Get Free Report)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.

See Also

Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.